Viewing Study NCT00184067


Ignite Creation Date: 2025-12-25 @ 12:36 AM
Ignite Modification Date: 2026-04-01 @ 12:53 PM
Study NCT ID: NCT00184067
Status: TERMINATED
Last Update Posted: 2014-05-21
First Post: 2005-09-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Continuation Booster Trial After a Vaccine Combining Tyrosinase/GP100/MART-1 Peptides Emulsified With Montanide ISA 51 With or Without GM-CSF for Patients With Melanoma
Sponsor: University of Southern California
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 10M-03-8
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators